Transplantation and Changing Management of Organ Failure

Proceedings of the 32nd International Conference on Transplantation and Changing Management of Organ Failure, 25–26 May, 2000

  • Editors
  • Pierre Cochat

Part of the Transplantation and Clinical Immunology book series (TRAC, volume 32)

Table of contents

  1. Front Matter
    Pages i-ix
  2. Past and future alternatives and strategies

  3. Liver replacement therapy

    1. Front Matter
      Pages 59-59
    2. Isabelle Méchet
      Pages 67-73
  4. Renal replacement therapy

    1. Front Matter
      Pages 75-75
    2. J. Traeger, R. Galland, E. Delawari, W. Arkouche
      Pages 97-105
    3. C. Pouteil-Noble, E. Villar, D. Babici, R. Ecochard
      Pages 115-128
  5. Pancreas replacement therapy

    1. Front Matter
      Pages 129-129
    2. X. Martin, P. Petruzzo, N. Lefrancois, L. Badet, J. M. Dubernard
      Pages 139-143
  6. Heart and lung replacement therapy

    1. Front Matter
      Pages 151-151
    2. P. Menasché
      Pages 159-162
    3. A. Clement
      Pages 169-172
  7. Emerging transplantations and management

    1. Front Matter
      Pages 173-173
    2. O. Goulet, D. Jan
      Pages 175-187
    3. O. Damour, A. Black, P. Pascal, F. Braye
      Pages 193-207
  8. Concluding remarks

    1. Front Matter
      Pages 209-209
    2. M. Manyalich, D. Paredes, C. Cabrer
      Pages 211-225
    3. Y. Matillon, D. Houssin
      Pages 227-237
    4. L. F. Ross, J. R. Thistlethwaite Jr.
      Pages 239-246
  9. Back Matter
    Pages 247-247

About this book


This book, the proceedings of the 32nd International Conference on Transplantation and Clinical Immunology, held in Lyon, France, on May 25-26, 2000, addresses novel issues in terms of changing indications for transplantation in the management of organ failure, whether humans will remain the only source for organ procurement, prospects for engineering in organ replacement, and whether transplantation will remain the most appropriate approach to organ failure. Some promising treatments are approached, such as enzymic and biochemical replacement, gene therapy, tolerance induction, stem cell transplantation, and xenotransplantation. In addition to the constant improvement in conservative management of organ failure in general, ongoing research in selected fields is reported in the proceedings, such as liver transplantation vs artificial liver, novel dialysis strategies vs evolving immunosuppression in kidney transplantation, islets transplantation and external implantable insulin pumps vs pancreas transplantation in diabetic patients, circulatory assistance and intramyocardial myoblast injection vs heart transplantation. Pivotal experience in selected emerging transplantations is included, that is, small bowel, limb, skin and neuronal transplantation. Such fascinating perspectives raise medical, economical, and ethical problems which are discussed in this book.


diseases gene therapy immunosuppression kidney liver transplantation organ organ transplantation stem cell transplantation transplantation

Bibliographic information